Molecular probes for the human adenosine receptors.
Adenosine receptors
Chemical biology
Covalent ligands
Fluorescent ligands
GPCR
PET ligands
Probes
Radioligands
Journal
Purinergic signalling
ISSN: 1573-9546
Titre abrégé: Purinergic Signal
Pays: Netherlands
ID NLM: 101250499
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
23
04
2020
accepted:
01
11
2020
pubmed:
15
12
2020
medline:
15
12
2021
entrez:
14
12
2020
Statut:
ppublish
Résumé
Adenosine receptors, G protein-coupled receptors (GPCRs) that are activated by the endogenous ligand adenosine, have been considered potential therapeutic targets in several disorders. To date however, only very few adenosine receptor modulators have made it to the market. Increased understanding of these receptors is required to improve the success rate of adenosine receptor drug discovery. To improve our understanding of receptor structure and function, over the past decades, a diverse array of molecular probes has been developed and applied. These probes, including radioactive or fluorescent moieties, have proven invaluable in GPCR research in general. Specifically for adenosine receptors, the development and application of covalent or reversible probes, whether radiolabeled or fluorescent, have been instrumental in the discovery of new chemical entities, the characterization and interrogation of adenosine receptor subtypes, and the study of adenosine receptor behavior in physiological and pathophysiological conditions. This review summarizes these applications, and also serves as an invitation to walk another mile to further improve probe characteristics and develop additional tags that allow the investigation of adenosine receptors and other GPCRs in even finer detail.
Identifiants
pubmed: 33313997
doi: 10.1007/s11302-020-09753-8
pii: 10.1007/s11302-020-09753-8
pmc: PMC7954947
doi:
Substances chimiques
Fluorescent Dyes
0
Molecular Probes
0
Receptors, Purinergic P1
0
Adenosine Triphosphate
8L70Q75FXE
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
85-108Références
Nucl Med Biol. 2009 Jan;36(1):3-10
pubmed: 19181263
J Med Chem. 2019 Apr 11;62(7):3539-3552
pubmed: 30869893
J Am Chem Soc. 2018 May 16;140(19):6067-6075
pubmed: 29420021
Mol Pharmacol. 2005 Jun;67(6):2137-47
pubmed: 15788741
J Med Chem. 2000 Dec 28;43(26):4973-80
pubmed: 11150167
Mol Pharmacol. 1992 Jul;42(1):123-33
pubmed: 1635550
Synapse. 1997 Dec;27(4):322-35
pubmed: 9372555
Annu Rev Biochem. 2008;77:383-414
pubmed: 18366325
ACS Chem Biol. 2015 Jun 19;10(6):1376-86
pubmed: 25860503
Drug Des Discov. 1999 Nov;16(3):217-26
pubmed: 10624567
EMBO Rep. 2013 Aug;14(8):726-32
pubmed: 23817552
J Med Chem. 2004 Jul 29;47(16):4041-53
pubmed: 15267242
Mol Pharmacol. 1994 May;45(5):871-7
pubmed: 8190104
Naunyn Schmiedebergs Arch Pharmacol. 1987 Aug;336(2):204-10
pubmed: 2825043
J Biol Chem. 1995 Jun 9;270(23):13987-97
pubmed: 7775460
PLoS One. 2011 Feb 28;6(2):e17338
pubmed: 21386999
Expert Rev Proteomics. 2006 Aug;3(4):399-408
pubmed: 16901199
Nucl Med Biol. 2016 May;43(5):309-17
pubmed: 27150034
Bioorg Med Chem Lett. 2013 Jan 1;23(1):26-36
pubmed: 23200243
Org Biomol Chem. 2013 Sep 14;11(34):5673-82
pubmed: 23881285
Medchemcomm. 2017 Aug 1;8(8):1659-1667
pubmed: 29250307
ACS Med Chem Lett. 2017 May 17;8(6):660-665
pubmed: 28626529
Expert Opin Drug Discov. 2016;11(1):79-90
pubmed: 26757171
Med Res Rev. 2018 Jan;38(1):5-56
pubmed: 28128443
Bioorg Med Chem. 2018 Sep 1;26(16):4650-4663
pubmed: 30104122
Synapse. 2007 Sep;61(9):778-84
pubmed: 17568431
Biochemistry. 2013 Dec 3;52(48):8625-32
pubmed: 24199838
Purinergic Signal. 2016 Mar;12(1):115-26
pubmed: 26647040
Biochem Pharmacol. 2012 Jun 1;83(11):1552-61
pubmed: 22402302
Purinergic Signal. 2019 Jun;15(2):139-153
pubmed: 30919204
Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):405-13
pubmed: 15549298
J Med Chem. 1996 Mar 1;39(5):1164-71
pubmed: 8676354
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7432-6
pubmed: 1323836
Mol Pharmacol. 1991 Apr;39(4):517-23
pubmed: 2017151
J Med Chem. 2004 Jul 15;47(15):3707-9
pubmed: 15239649
J Fluoresc. 1992 Dec;2(4):217-223
pubmed: 23772170
Bioorg Med Chem Lett. 2011 May 1;21(9):2740-5
pubmed: 21185184
Mol Pharmacol. 1996 Oct;50(4):789-98
pubmed: 8863823
Neurochem Int. 2013 Jul;63(1):42-6
pubmed: 23619397
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6572-6
pubmed: 2771944
J Biol Chem. 1985 Nov 25;260(27):14659-64
pubmed: 2997218
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4673-8
pubmed: 15070776
Mol Pharmacol. 1994 May;45(5):978-82
pubmed: 8190112
Am J Physiol. 1992 Mar;262(3 Pt 2):H661-71
pubmed: 1558173
Mol Pharmacol. 1986 Oct;30(4):403-9
pubmed: 3020390
Int Rev Neurobiol. 2014;119:51-69
pubmed: 25175960
SLAS Discov. 2017 Feb;22(2):166-175
pubmed: 27577981
Biochem Pharmacol. 2010 Oct 15;80(8):1180-9
pubmed: 20599769
Science. 2008 Nov 21;322(5905):1211-7
pubmed: 18832607
Circulation. 1998 Aug 18;98(7):711-8
pubmed: 9715864
Chem Biol. 2012 Sep 21;19(9):1105-15
pubmed: 22999879
Bioorg Med Chem Lett. 2000 Feb 7;10(3):209-11
pubmed: 10698437
Bioorg Med Chem Lett. 2002 Feb 11;12(3):501-3
pubmed: 11814828
Nucl Med Biol. 2008 Jan;35(1):61-6
pubmed: 18158944
Eur J Med Chem. 2020 Jan 15;186:111886
pubmed: 31787357
Br J Pharmacol. 1998 Apr;123(7):1425-33
pubmed: 9579739
Curr Med Chem. 2011;18(31):4820-35
pubmed: 21919845
Eur J Neurosci. 2001 Nov;14(9):1567-70
pubmed: 11722618
J Mol Recognit. 1989 Dec;2(4):170-8
pubmed: 2561548
Naunyn Schmiedebergs Arch Pharmacol. 1996 Oct;354(4):539-41
pubmed: 8897460
J Neurochem. 1995 Nov;65(5):2072-9
pubmed: 7595492
Drug Dev Res. 1993 Aug 1;29(4):292-298
pubmed: 22787287
Biochem Pharmacol. 2001 Mar 15;61(6):657-63
pubmed: 11266650
Cell. 2017 Feb 23;168(5):867-877.e13
pubmed: 28235198
J Med Chem. 2016 Dec 22;59(24):11182-11194
pubmed: 27958734
J Med Chem. 2000 Nov 16;43(23):4359-62
pubmed: 11087559
Br J Pharmacol. 2012 Jul;166(6):1846-59
pubmed: 22324512
Neurobiol Aging. 2007 Dec;28(12):1914-24
pubmed: 16996650
J Neurochem. 1990 Nov;55(5):1763-71
pubmed: 2213023
J Med Chem. 1999 Feb 25;42(4):706-21
pubmed: 10052977
J Med Chem. 2014 Nov 13;57(21):9204-10
pubmed: 25279444
Neuropharmacology. 2018 Dec;143:106-112
pubmed: 30253174
Brain Res. 1998 Oct 19;808(2):320-3
pubmed: 9767181
Br J Pharmacol. 2020 Mar;177(5):978-991
pubmed: 31877233
Arch Pharm Res. 2013 Mar;36(3):293-305
pubmed: 23456693
J Med Chem. 2018 Sep 13;61(17):7892-7901
pubmed: 30080404
Bioorg Med Chem Lett. 2001 Mar 26;11(6):815-8
pubmed: 11277527
Bioorg Med Chem Lett. 2004 Jul 5;14(13):3607-10
pubmed: 15177484
Mol Pharmacol. 1990 Aug;38(2):177-83
pubmed: 2385230
Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):679-83
pubmed: 2615857
Synapse. 2017 Aug;71(8):
pubmed: 28407307
J Neurochem. 1992 Aug;59(2):425-31
pubmed: 1629718
Mol Pharmacol. 1997 Sep;52(3):491-8
pubmed: 9281612
Mol Pharmacol. 2000 May;57(5):968-75
pubmed: 10779381
Nat Rev Drug Discov. 2006 Mar;5(3):247-64
pubmed: 16518376
Eur J Pharmacol. 2009 Aug 15;616(1-3):107-14
pubmed: 19545560
Methods Cell Biol. 2016;132:191-215
pubmed: 26928545
Neuroimage. 2003 Aug;19(4):1760-9
pubmed: 12948730
J Med Chem. 1989 May;32(5):1043-51
pubmed: 2709373
Purinergic Signal. 2017 Jun;13(2):191-201
pubmed: 27915383
Bioorg Med Chem Lett. 2010 Oct 1;20(19):5690-4
pubmed: 20801028
J Med Chem. 2016 Mar 10;59(5):2151-62
pubmed: 26821136
Biochem Pharmacol. 2010 Apr 1;79(7):967-73
pubmed: 19917269
J Nucl Med. 2012 Nov;53(11):1723-9
pubmed: 22966134
ChemMedChem. 2016 Jul 19;11(14):1488-98
pubmed: 27347648
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4243-4248
pubmed: 28373571
J Org Chem. 2004 May 14;69(10):3308-18
pubmed: 15132536
Bioorg Med Chem Lett. 2007 Mar 1;17(5):1376-80
pubmed: 17236762
Curr Med Chem. 2014;21(3):312-28
pubmed: 24059232
Bioconjug Chem. 1999 Jul-Aug;10(4):667-77
pubmed: 10411465
Eur J Pharmacol. 2001 Jan 12;411(3):205-10
pubmed: 11164377
Neurology. 2011 May 24;76(21):1811-6
pubmed: 21606452
J Nucl Med. 2015 Apr;56(4):586-91
pubmed: 25698783
Bioorg Med Chem. 2018 Dec 1;26(22):5885-5895
pubmed: 30415894
J Med Chem. 2009 Jul 9;52(13):3994-4006
pubmed: 19569717
J Med Chem. 1994 Aug 19;37(17):2704-12
pubmed: 8064798
Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):1-9
pubmed: 9459566
Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1210-20
pubmed: 24566949
Mol Pharmacol. 1988 Jun;33(6):585-91
pubmed: 3380075
Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):521-6
pubmed: 8321327
Chem Biol. 2004 Apr;11(4):535-46
pubmed: 15123248
Neuropharmacology. 2015 Nov;98:68-77
pubmed: 25937210
Biochem Pharmacol. 2004 Jul 15;68(2):305-12
pubmed: 15194002
J Nucl Med. 2005 Jan;46(1):32-7
pubmed: 15632030
J Med Chem. 2014 Aug 14;57(15):6765-80
pubmed: 25061687
ACS Chem Biol. 2016 Jul 15;11(7):1870-9
pubmed: 27115427
Purinergic Signal. 2009 Mar;5(1):31-7
pubmed: 18528782
J Med Chem. 2018 May 24;61(10):4301-4316
pubmed: 29681156
J Pharmacol Exp Ther. 1989 Dec;251(3):888-93
pubmed: 2600819
ACS Med Chem Lett. 2014 Jul 11;5(9):1043-8
pubmed: 25221664
J Med Chem. 2020 Mar 12;63(5):2656-2672
pubmed: 31887252
Eur J Pharm Sci. 2000;10(4):259-65
pubmed: 10838015
Biochem Pharmacol. 2010 Jan 1;79(1):48-56
pubmed: 19665453
Purinergic Signal. 2018 Sep;14(3):223-233
pubmed: 29752618
Expert Opin Drug Discov. 2018 Oct;13(10):933-947
pubmed: 30249143
Front Pharmacol. 2017 Dec 13;8:908
pubmed: 29321740
J Nucl Med. 2013 Oct;54(10):1760-7
pubmed: 23970369
Mol Pharmacol. 1999 Oct;56(4):705-13
pubmed: 10496952
Br J Pharmacol. 2019 Apr;176(7):864-878
pubmed: 30644086
Assay Drug Dev Technol. 2004 Jun;2(3):290-9
pubmed: 15285910
Ann Nucl Med. 2000 Apr;14(2):81-9
pubmed: 10830524
J Med Chem. 2018 Nov 21;61(22):9966-9975
pubmed: 30359014
Trends Biotechnol. 2000 Feb;18(2):64-77
pubmed: 10652511
Biochem Pharmacol. 2020 Oct;180:114144
pubmed: 32653590
J Neurochem. 2012 Nov;123(3):373-84
pubmed: 22924752
Eur J Pharmacol. 2007 Feb 5;556(1-3):14-8
pubmed: 17126322
ChemMedChem. 2016 Sep 6;11(17):1936-43
pubmed: 27407017
Mol Pharmacol. 1988 Dec;34(6):724-8
pubmed: 3200248
J Biol Chem. 1985 Sep 5;260(19):10806-11
pubmed: 2993290
Br J Pharmacol. 2010 Nov;161(6):1219-37
pubmed: 20132208
Bioorg Med Chem Lett. 2002 Nov 4;12(21):3179-82
pubmed: 12372528
Biochem Biophys Res Commun. 1994 Aug 30;203(1):570-6
pubmed: 8074705
J Med Chem. 1988 Apr;31(4):752-6
pubmed: 3351851
Br J Pharmacol. 1997 Jun;121(3):353-60
pubmed: 9179373
J Biochem. 1996 Aug;120(2):459-65
pubmed: 8889834
Contrast Media Mol Imaging. 2018 Feb 13;2018:1269830
pubmed: 29666562
Bioconjug Chem. 2013 Nov 20;24(11):1907-16
pubmed: 24094147
J Med Chem. 2001 Aug 16;44(17):2735-42
pubmed: 11495585